These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12174057)

  • 1. Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience.
    Sovak M; Seligson AL; Kucerova R; Bienova M; Hajduch M; Bucek M
    Dermatol Surg; 2002 Aug; 28(8):678-85. PubMed ID: 12174057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial.
    Fischer TW; Burmeister G; Schmidt HW; Elsner P
    Br J Dermatol; 2004 Feb; 150(2):341-5. PubMed ID: 14996107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
    Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
    J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia.
    Dhurat R; Chitallia J; May TW; Jayaraaman AM; Madhukara J; Anandan S; Vaidya P; Klenk A
    Skin Pharmacol Physiol; 2017; 30(6):298-305. PubMed ID: 29055953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finasteride increases anagen hair in men with androgenetic alopecia.
    Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
    Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical valproic acid increases the hair count in male patients with androgenetic alopecia: a randomized, comparative, clinical feasibility study using phototrichogram analysis.
    Jo SJ; Shin H; Park YW; Paik SH; Park WS; Jeong YS; Shin HJ; Kwon O
    J Dermatol; 2014 Apr; 41(4):285-91. PubMed ID: 24533507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris.
    Marks DH; Prasad S; De Souza B; Burns LJ; Senna MM
    Am J Clin Dermatol; 2020 Apr; 21(2):245-254. PubMed ID: 31832993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenetic alopecia: treatment results with topical minoxidil.
    Roberts JL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):705-10. PubMed ID: 3549805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
    Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
    Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of telogen rate and increase of hair density in androgenetic alopecia by a cosmetic product: Results of a randomized, prospective, vehicle-controlled double-blind study in men.
    Welzel J; Wolff HH; Gehring W
    J Cosmet Dermatol; 2022 Mar; 21(3):1057-1064. PubMed ID: 33955628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.
    Kucerova R; Bienova M; Kral M; Bouchal J; Trtkova KS; Burdova A; Student V; Kolar Z
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):91-6. PubMed ID: 24665929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author's transl)].
    Orfanos CE; Vogels L
    Dermatologica; 1980; 161(2):124-32. PubMed ID: 7398983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.